Nutrien (NYSE:NTR) Price Target Raised to $80.00 at JPMorgan Chase & Co.

Nutrien (NYSE:NTRGet Free Report) had its target price boosted by JPMorgan Chase & Co. from $78.00 to $80.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 12.11% from the company’s current price.

A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Nutrien from $77.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 8th. TD Securities restated a “buy” rating on shares of Nutrien in a research report on Wednesday, May 6th. Canadian Imperial Bank of Commerce dropped their target price on Nutrien from $90.00 to $88.00 and set an “outperformer” rating for the company in a research report on Thursday, April 30th. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 target price for the company in a research report on Thursday, April 30th. Finally, Jefferies Financial Group upgraded Nutrien from a “hold” rating to a “buy” rating and boosted their target price for the stock from $74.00 to $96.00 in a research report on Thursday, March 12th. Eleven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Nutrien has a consensus rating of “Moderate Buy” and an average price target of $82.75.

View Our Latest Report on Nutrien

Nutrien Price Performance

Nutrien stock traded up $3.03 on Monday, reaching $71.36. The company’s stock had a trading volume of 2,748,892 shares, compared to its average volume of 3,519,182. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. The company has a market cap of $34.31 billion, a price-to-earnings ratio of 14.53 and a beta of 0.64. The business’s fifty day moving average price is $74.93 and its 200 day moving average price is $66.96. Nutrien has a twelve month low of $53.03 and a twelve month high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business’s revenue was up 18.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.11 earnings per share. Equities analysts expect that Nutrien will post 5.09 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutrien

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NTR. Wellington Management Group LLP increased its holdings in Nutrien by 440.2% in the fourth quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company’s stock valued at $1,008,713,000 after purchasing an additional 13,313,817 shares during the last quarter. Norges Bank bought a new stake in Nutrien in the fourth quarter valued at about $412,635,000. Arrowstreet Capital Limited Partnership increased its holdings in Nutrien by 19.1% in the third quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company’s stock valued at $834,962,000 after purchasing an additional 2,276,651 shares during the last quarter. TD Asset Management Inc increased its holdings in Nutrien by 21.2% in the fourth quarter. TD Asset Management Inc now owns 8,928,534 shares of the company’s stock valued at $551,821,000 after purchasing an additional 1,559,673 shares during the last quarter. Finally, DJE Kapital AG increased its holdings in Nutrien by 1,373.6% in the first quarter. DJE Kapital AG now owns 1,534,869 shares of the company’s stock valued at $116,111,000 after purchasing an additional 1,430,708 shares during the last quarter. Institutional investors own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.